YU9003A - Farmaceutski sastav koji sadrži citalopram - Google Patents

Farmaceutski sastav koji sadrži citalopram

Info

Publication number: YU9003A
Authority: YU; Yugoslavia
Prior art keywords: citalopram; pharmaceutical composition; composition containing; containing citalopram; mixture
Prior art date: 2000-08-10

Application number

YU9003A

Other languages

English (en)

Serbo-Croatian (sh)

Inventor

Ken Liljegren

Per Holm

Ole Nielsen

Sven Wagner

Original Assignee

H. Lundbeck A/S

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-10

Filing date

2001-07-30

Publication date

2006-05-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26068858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU9003(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-07-30 Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S

2006-05-25 Publication of YU9003A publication Critical patent/YU9003A/sh

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

YU9003A 2000-08-10 2001-07-30 Farmaceutski sastav koji sadrži citalopram YU9003A (sh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200001202		2000-08-10
DKPA200001614		2000-10-27

Publications (1)

Publication Number	Publication Date
YU9003A true YU9003A (sh)	2006-05-25

Family

ID=26068858

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
YU9003A YU9003A (sh)	2000-08-10	2001-07-30	Farmaceutski sastav koji sadrži citalopram

Country Status (34)

Country	Link
EP (1)	EP1318805A2 (fr)
JP (1)	JP2003531153A (fr)
KR (1)	KR20030024833A (fr)
CN (1)	CN1446089A (fr)
AR (1)	AR030095A1 (fr)
AT (1)	AT5744U1 (fr)
AU (2)	AU2001100198B4 (fr)
BE (1)	BE1013559A6 (fr)
BG (1)	BG107578A (fr)
BR (1)	BR0113250A (fr)
CA (1)	CA2353693C (fr)
CH (2)	CH694241A5 (fr)
CZ (1)	CZ2003397A3 (fr)
DE (2)	DE10139115A1 (fr)
EA (1)	EA200300247A1 (fr)
ES (1)	ES2172481B2 (fr)
FI (1)	FI5176U1 (fr)
FR (1)	FR2812811B1 (fr)
GB (1)	GB2368014B (fr)
GR (1)	GR1004193B (fr)
HR (1)	HRP20030054A2 (fr)
HU (1)	HUP0103071A3 (fr)
IE (1)	IES20010693A2 (fr)
IL (1)	IL154050A0 (fr)
IS (1)	IS6021A (fr)
IT (1)	ITMI20011637A1 (fr)
MX (1)	MXPA03000837A (fr)
NL (1)	NL1018741C1 (fr)
NO (1)	NO20013891L (fr)
NZ (1)	NZ523785A (fr)
PL (1)	PL359824A1 (fr)
SK (1)	SK2842003A3 (fr)
WO (1)	WO2001080619A2 (fr)
YU (1)	YU9003A (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IS6021A (is) *	2000-08-10	2001-10-20	H. Lundbeck A/S	Lyfjasamsetningar sem innihalda sítalópram
AU2001100195B4 (en) *	2001-01-05	2001-12-20	H Lundbeck As	Pharmaceutical composition containing citalopram.
GB0206708D0 (en) *	2002-03-21	2002-05-01	Cipla Ltd	Pharmaceutical salts
US6812355B2 (en)	2002-10-22	2004-11-02	Sekhsaria Chemicals Limited	Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
BR0317623A (pt) *	2002-12-23	2005-11-29	Lundbeck & Co As H	Escitalopram, composição farmacêutica, e, uso de hidrobrometo de escitalopram
WO2004103361A2 (fr) *	2003-05-20	2004-12-02	Ranbaxy Laboratories Limited	Forme posologique pharmaceutique de citalopram
HU227491B1 (en) *	2003-11-25	2011-07-28	Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag	Tablet containing citalopram hydrogen bromide
WO2006038217A1 (fr) *	2004-10-05	2006-04-13	Strides Acrolab Limited	Systeme ameliore d’administration de medicaments a base de bromhydrate de citalopram et processus de production dudit systeme
US7834201B2 (en)	2005-06-22	2010-11-16	H. Lundbeck A/S	Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CN100353939C (zh) *	2006-01-05	2007-12-12	昆明积大制药有限公司	含西酞普兰和环糊精的抗抑郁口服药用组合物
GB2446847B (en) *	2007-02-02	2012-02-22	Ubiquisys Ltd	Location of Basestation
WO2017020841A1 (fr) *	2015-08-03	2017-02-09	深圳信立泰药业股份有限公司	Composition pharmaceutique contenant du lcz696 et son procédé de préparation
EP4277661A1 (fr) *	2021-01-18	2023-11-22	Anton Frenkel	Forme posologique pharmaceutique
EP4661849A1 (fr)	2023-02-07	2025-12-17	Kinast, Lasse	Forme pharmaceutique orale à libération immédiate d'escitalopram ou de racémate de celui-ci avec une teneur accrue en api

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1358915A (en) *	1919-04-14	1920-11-16	Amici Domenico	Aeroplane
GB1358915A (en) *	1971-09-13	1974-07-03	Merck & Co Inc	Directly compressed tablet and composition therefor
GB1526331A (en)	1976-01-14	1978-09-27	Kefalas As	Phthalanes
GB8419963D0 (en)	1984-08-06	1984-09-12	Lundbeck & Co As H	Intermediate compound and method
GB8814057D0 (en) *	1988-06-14	1988-07-20	Lundbeck & Co As H	New enantiomers & their isolation
US5296507A (en) *	1990-09-06	1994-03-22	H.Lundbeck A/S	Treatment of cerbrovascular disorders
EP0714663A3 (fr) *	1994-11-28	1997-01-15	Lilly Co Eli	Potentialisation d'un médicament par un antagoniste du récepteur sérotonine 1A
GB9714841D0 (en) *	1997-07-14	1997-09-17	Smithkline Beecham Plc	Treatment method
GB2357762B (en) *	2000-03-13	2002-01-30	Lundbeck & Co As H	Crystalline base of citalopram
US6977306B2 (en)	2000-05-02	2005-12-20	Sumitomo Chemical Company, Limited	Citalopram hydrobromide crystal and method for crystallization thereof
IS6021A (is) *	2000-08-10	2001-10-20	H. Lundbeck A/S	Lyfjasamsetningar sem innihalda sítalópram

2001
- 2001-07-24 IS IS6021A patent/IS6021A/is unknown
- 2001-07-24 IE IE20010693A patent/IES20010693A2/en not_active IP Right Cessation
- 2001-07-24 CA CA002353693A patent/CA2353693C/fr not_active Expired - Lifetime
- 2001-07-26 HU HU0103071A patent/HUP0103071A3/hu unknown
- 2001-07-26 AU AU2001100198A patent/AU2001100198B4/en not_active Expired
- 2001-07-27 IT IT2001MI001637A patent/ITMI20011637A1/it unknown
- 2001-07-30 KR KR10-2003-7001683A patent/KR20030024833A/ko not_active Ceased
- 2001-07-30 EA EA200300247A patent/EA200300247A1/ru unknown
- 2001-07-30 MX MXPA03000837A patent/MXPA03000837A/es unknown
- 2001-07-30 YU YU9003A patent/YU9003A/sh unknown
- 2001-07-30 AU AU2001279591A patent/AU2001279591A1/en not_active Abandoned
- 2001-07-30 JP JP2001577732A patent/JP2003531153A/ja not_active Withdrawn
- 2001-07-30 NZ NZ523785A patent/NZ523785A/en unknown
- 2001-07-30 IL IL15405001A patent/IL154050A0/xx unknown
- 2001-07-30 SK SK284-2003A patent/SK2842003A3/sk not_active Application Discontinuation
- 2001-07-30 BR BR0113250-4A patent/BR0113250A/pt not_active IP Right Cessation
- 2001-07-30 CN CN01813752A patent/CN1446089A/zh active Pending
- 2001-07-30 CZ CZ2003397A patent/CZ2003397A3/cs unknown
- 2001-07-30 PL PL01359824A patent/PL359824A1/xx not_active Application Discontinuation
- 2001-07-30 WO PCT/DK2001/000520 patent/WO2001080619A2/fr not_active Ceased
- 2001-07-30 EP EP01957768A patent/EP1318805A2/fr not_active Withdrawn
- 2001-07-30 HR HR20030054A patent/HRP20030054A2/hr not_active Application Discontinuation
- 2001-07-31 AR ARP010103662A patent/AR030095A1/es not_active Application Discontinuation
- 2001-07-31 GR GR20010100377A patent/GR1004193B/el unknown
- 2001-07-31 GB GB0118579A patent/GB2368014B/en not_active Expired - Fee Related
- 2001-08-07 AT AT0062401U patent/AT5744U1/de not_active IP Right Cessation
- 2001-08-08 CH CH01422/03A patent/CH694241A5/de not_active IP Right Cessation
- 2001-08-08 CH CH01469/01A patent/CH694242A5/de not_active IP Right Cessation
- 2001-08-08 FR FR0110586A patent/FR2812811B1/fr not_active Expired - Fee Related
- 2001-08-09 DE DE10139115A patent/DE10139115A1/de not_active Ceased
- 2001-08-09 DE DE20113195U patent/DE20113195U1/de not_active Ceased
- 2001-08-09 FI FI20010303U patent/FI5176U1/fi active
- 2001-08-09 NO NO20013891A patent/NO20013891L/no not_active Application Discontinuation
- 2001-08-09 ES ES200101877A patent/ES2172481B2/es not_active Expired - Fee Related
- 2001-08-10 NL NL1018741A patent/NL1018741C1/nl not_active IP Right Cessation
- 2001-08-10 BE BE2001/0537A patent/BE1013559A6/fr not_active IP Right Cessation
2003
- 2003-02-21 BG BG107578A patent/BG107578A/bg unknown

Also Published As

Publication number	Publication date
DE10139115A1 (de)	2002-03-28
AR030095A1 (es)	2003-08-13
HUP0103071A3 (en)	2002-12-28
IS6021A (is)	2001-10-20
ITMI20011637A1 (it)	2003-01-27
GB2368014B (en)	2004-06-23
BE1013559A6 (fr)	2002-03-05
CA2353693C (fr)	2003-07-22
IES20010693A2 (en)	2002-07-10
BR0113250A (pt)	2003-06-24
SK2842003A3 (en)	2003-09-11
FR2812811A1 (fr)	2002-02-15
BG107578A (bg)	2003-09-30
NL1018741C1 (nl)	2002-02-12
NO20013891D0 (no)	2001-08-09
EP1318805A2 (fr)	2003-06-18
CH694242A5 (de)	2004-10-15
PL359824A1 (en)	2004-09-06
CA2353693A1 (fr)	2002-01-22
FI5176U1 (fi)	2001-12-27
AU2001100198B4 (en)	2002-06-13
HUP0103071A2 (hu)	2002-05-29
JP2003531153A (ja)	2003-10-21
WO2001080619A3 (fr)	2002-02-21
AU2001279591A1 (en)	2001-11-07
KR20030024833A (ko)	2003-03-26
WO2001080619A2 (fr)	2001-11-01
CZ2003397A3 (cs)	2003-06-18
AT5744U1 (de)	2002-11-25
ES2172481B2 (es)	2004-08-01
MXPA03000837A (es)	2003-06-06
CH694241A5 (de)	2004-10-15
GB2368014A (en)	2002-04-24
ITMI20011637A0 (it)	2001-07-27
NZ523785A (en)	2004-09-24
GR1004193B (el)	2003-03-24
FR2812811B1 (fr)	2006-08-18
HU0103071D0 (en)	2001-10-28
ES2172481A1 (es)	2002-09-16
EA200300247A1 (ru)	2003-06-26
GB0118579D0 (en)	2001-09-19
GR20010100377A (el)	2002-09-06
IL154050A0 (en)	2003-07-31
DE20113195U1 (de)	2001-11-15
HRP20030054A2 (en)	2005-02-28
AU2001100198A4 (en)	2001-08-16
NO20013891L (no)	2002-02-11
CN1446089A (zh)	2003-10-01

Publication	Publication Date	Title
ES2172481A1 (es)	2002-09-16	Composicion farmaceutica que contiene citalopram.
DE69620606D1 (de)	2002-05-16	Feste oral anzuwendende arzeneiform
DK1117383T3 (da)	2006-04-03	Doseringsformer omfattende terapeutisk formulering
RU2003116058A (ru)	2004-09-10	Композиции гидрокодона с контролируемым высвобождением
EP1246622A4 (fr)	2004-06-16	Nouvelles formes posologiques de benzimidazole substitue
YU21999A (sh)	2002-03-18	Farmaceutske smese i postupak za njihovo dobijanje
MX2007015480A (es)	2008-04-29	Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
AP2003002763A0 (en)	2003-03-31	Controlled release formulations for oral administration
RU2003100507A (ru)	2004-05-10	Фармацевтические композиции
MXPA03011317A (es)	2004-03-19	Comprimido masticable que comprende paracetamol.
SE8901003D0 (sv)	1989-03-21	Snabbloesliga preparat
HUP0203148A2 (hu)	2003-01-28	Mirtazapint tartalmazó orálisan dezintegrálódó készítmény
CA2432177A1 (fr)	2002-06-27	Medicaments pour la prevention et/ou la therapie de l'endometriose
TW200517127A (en)	2005-06-01	Novel composition
YU54503A (sh)	2006-05-25	Farmaceutski sastav koji sadrži citalopram
GEP20043377B (en)	2004-04-13	Pharmaceutical Complex
TNSN06003A1 (en)	2007-10-03	Saquinavir mesylate oral dosage form
SI1530459T1 (sl)	2010-08-31	Oralni farmacevtski sestavek za mehke kapsule, ki vsebujejo vinorelbin in postopek obdelave
TW200500085A (en)	2005-01-01	Sustained-release pharmaceutical composition for lung administration
MY131159A (en)	2007-07-31	New pharmaceutical compositions containing epinastine and pseudoephedrine
RU2002126216A (ru)	2004-03-20	Фармацевтическая композиция для лечения и профилактики фиброза и цирроза печени
MY145885A (en)	2012-05-15	Controlled release formulations for oral administration
CA2388431A1 (fr)	2003-11-30	Composition pharmaceutique orale contenant de la vinorelbine pour encapsulation dans des capsules molles et methode de traitement
PE20030546A1 (es)	2003-08-12	Una forma de unidad de dosis farmaceutica del tipo de capsulas rigidas que contiene clonixinato de lisina, un procedimiento para su preparacion y el uso de dicha unidad de dosis como analgesico y/o antiinflamatorio
PL355467A1 (en)	2004-02-23	Pharmaceutical composition for filling hard gelatine capsules, method of producing pharmaceutical composition for filling hard gelatine capsules and hard the hard gelatine capsules